NYSE:NVST • US29415F1049
The current stock price of NVST is 28.52 USD. Today NVST is down by -0.52%. In the past month the price increased by 23.26%. In the past year, price increased by 55.56%.
ChartMill assigns a technical rating of 10 / 10 to NVST. When comparing the yearly performance of all stocks, NVST is one of the better performing stocks in the market, outperforming 91.63% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to NVST. NVST has only an average score on both its financial health and profitability.
On February 5, 2026 NVST reported an EPS of 0.38 and a revenue of 750.60M. The company beat EPS expectations (15.44% surprise) and beat revenue expectations (8.23% surprise).
21 analysts have analysed NVST and the average price target is 29.24 USD. This implies a price increase of 2.52% is expected in the next year compared to the current price of 28.52.
For the next year, analysts expect an EPS growth of 8.23% and a revenue growth 7.6% for NVST
Over the last trailing twelve months NVST reported a non-GAAP Earnings per Share(EPS) of 1.2. The EPS increased by 64.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.73% | ||
| ROA | 0.83% | ||
| ROE | 1.51% | ||
| Debt/Equity | 0.47 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.78 | 197.553B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.1 | 176.649B | ||
| SYK | STRYKER CORP | 25.4 | 147.075B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.74 | 109.521B | ||
| IDXX | IDEXX LABORATORIES INC | 43.87 | 50.748B | ||
| BDX | BECTON DICKINSON AND CO | 10.86 | 49.634B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.84 | 49.488B | ||
| RMD | RESMED INC | 21.09 | 37.626B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.72 | 35.608B | ||
| DXCM | DEXCOM INC | 29.05 | 28.503B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.19 | 19.416B | ||
| PODD | INSULET CORP | 38.62 | 17.013B | ||
| HOLX | HOLOGIC INC | 15.03 | 16.846B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
ENVISTA HOLDINGS CORP
200 S. Kraemer Blvd., Bldg. E
Brea CALIFORNIA 92821 US
CEO: Amir Aghdaei
Employees: 12000
Phone: 17148175418
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
The current stock price of NVST is 28.52 USD. The price decreased by -0.52% in the last trading session.
NVST does not pay a dividend.
NVST has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ENVISTA HOLDINGS CORP (NVST) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NVST.
You can find the ownership structure of ENVISTA HOLDINGS CORP (NVST) on the Ownership tab.